Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT04835597 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 27
Last updated 2024-08-26
Summary
This study assesses the performance status in stage I-III triple negative breast cancer patients who are receiving neoadjuvant chemotherapy. Information collected in this study may help doctors learn if movement and fitness trackers can be used to predict side effects in cancer patients receiving chemotherapy.
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIA Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
- Triple-Negative Breast Carcinoma
Interventions
- BEHAVIORAL
-
Behavioral Assessment
Complete movement assessment
- OTHER
-
Electronic Health Record Review
SAE data is collected
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Meghan Karuturi, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-15
- Primary Completion
- 2024-08-21
- Completion
- 2024-08-21
Countries
- United States
Study Locations
More Related Trials
-
Electronic Medical Record-Based Nudge to Reduce SLNB
NCT06006910 ·Status: COMPLETED
-
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
NCT01007890 ·Status: TERMINATED
-
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024 ·Status: ACTIVE_NOT_RECRUITING
-
Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib
NCT05277935 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
NCT00033397 ·Status: COMPLETED
-
Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer
NCT04897009 ·Status: ACTIVE_NOT_RECRUITING
-
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
NCT03568448 ·Status: ACTIVE_NOT_RECRUITING
-
Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts
NCT02042456 ·Status: TERMINATED
-
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
NCT05877859 ·Status: RECRUITING
-
Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy
NCT00580086 ·Status: COMPLETED
-
Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT02688257 ·Status: COMPLETED
-
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069 ·Status: UNKNOWN
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN
-
Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
NCT07327970 ·Status: RECRUITING
-
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891 ·Status: COMPLETED ·Phase: NA
-
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
NCT02494869 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System
NCT02690805 ·Status: COMPLETED
-
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
NCT03188393 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer
NCT03289195 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study
NCT00282529 ·Status: TERMINATED ·Phase: NA
-
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
NCT02587663 ·Status: COMPLETED ·Phase: NA
-
Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery
NCT00233974 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749 ·Status: NOT_YET_RECRUITING
-
Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer
NCT02455882 ·Status: TERMINATED
-
Exercise, Fitness and Tumor Profiling in Breast Cancer Patients
NCT03424915 ·Status: ACTIVE_NOT_RECRUITING